Hints and tips:
...AstraZeneca Plc has made a preliminary approach to rival drugmaker Gilead Sciences Inc. about a potential merger, according to people familiar with the matter, in what would be the biggest health-care deal...
...Michael Weinstein, head of the Los Angeles-based Aids Healthcare Foundation, which last year issued 14,000 HIV tests and gave away 38.5m condoms, initially declared PrEP to be a “party drug” and a “public...
...Michael Weinstein, president of the Aids Healthcare Foundation, has waged a campaign against Truvada, which he describes as a “party drug” — a reference to the fact that he believes it will reduce people...
...Tensions over pricing have been growing for more than a year since Gilead Sciences launched a breakthrough medicine called Sovaldi, which cures most cases of hepatitis C within weeks — at a cost of $84,000...
...The Aids Healthcare Foundation, a US-based HIV treatment and advocacy group, cautioned this autumn that preventive use should not be pursued “at the risk of contributing to, rather than controlling, the...
...Kevin Frost, head of amfAR, the Foundation for Aids Research, welcomed the findings but warned of “the incredible costs and other logistical hurdles that will be faced in trying to operationalise this approach...
...A €4.7m ($6m, £4m) initial budget for the first year has been allocated for the pool, which has just been incorporated as a Swiss foundation....
...A survey released this week by the Kaiser Family Foundation, a US think tank, shows disbursement for Aids from international donors already slipping, from $7.7bn in 2008 to $7.6bn in 2009, after a sixfold...
International Edition